Insider Trading History of Reali Kenneth Michael

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Reali Kenneth Michael since 2012. This trader's CIK number is 1480801. At the time of last reporting, Reali Kenneth Michael was the Chief Executive Officer of Bioventus Inc.. (stock ticker symbol BVS). Also see all insider trading activities at Bioventus Inc..

Note that in the past Reali Kenneth Michael also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Trans1 Inc (BAXS) by Reali Kenneth Michael

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 BAXS 17,050 $8,833 0 $0 0 $0
2013 BAXS 10,500 $11,644 0 $0 0 $0
2012 BAXS 7,000 $18,095 0 $0 0 $0

Yearly summary of insider trading at Bioventus Inc. (BVS) by Reali Kenneth Michael

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 BVS 0 $0 9,811 $13,627 28,721 $0
2021 BVS 11,175 $148,533 0 $0 0 $0


Insider trading activities at 2 companies by Reali Kenneth Michael:

1. Trans1 Inc (BAXS)

2. Bioventus Inc. (BVS)

Table 1. Insider trading of Trans1 Inc (BAXS) by Reali Kenneth Michael

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-08-15 BAXS Buy 10,000 .38 3,800
2014-05-12 BAXS Buy 7,050 .71 5,033
2013-12-05 BAXS Buy 10,500 1.11 11,644
2012-06-07 TSON Buy 7,000 2.58 18,095

Table 2. Insider trading of Bioventus Inc. (BVS) by Reali Kenneth Michael

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-03-15 BVS Sale 9,811 1.39 13,627
2023-03-14 BVS Option Ex 28,721 .00 0
2021-09-09 BVS Buy 1,800 14.81 26,658
2021-02-11 BVS Buy 9,375 13.00 121,875

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Reali Kenneth Michael (Chief Executive Officer of Bioventus Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.